Shiau CW - Search Results

1

Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.

Liu CY, Chen KF, Chao TI, Chu PY, Huang CT, Huang TT, Yang HP, Wang WL, Lee CH, Lau KY, Tsai WC, Su JC, Wu CY, Chen MH, Shiau CW, Tseng LM. Liu CY, et al. Among authors: shiau cw. J Mol Med (Berl). 2017 Sep;95(9):965-975. doi: 10.1007/s00109-017-1549-x. Epub 2017 Jun 4. J Mol Med (Berl). 2017. PMID: 28578456

2

Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.

Huang JW, Shiau CW, Yang YT, Kulp SK, Chen KF, Brueggemeier RW, Shapiro CL, Chen CS. Huang JW, et al. Among authors: shiau cw. Mol Pharmacol. 2005 Apr;67(4):1342-8. doi: 10.1124/mol.104.007732. Epub 2005 Jan 13. Mol Pharmacol. 2005. PMID: 15653552

3

Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.

Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS. Shiau CW, et al. Cancer Res. 2005 Feb 15;65(4):1561-9. doi: 10.1158/0008-5472.CAN-04-1677. Cancer Res. 2005. PMID: 15735046

4

Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.

Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL. Chen KF, et al. Among authors: shiau cw. Clin Cancer Res. 2010 Nov 1;16(21):5189-99. doi: 10.1158/1078-0432.CCR-09-3389. Epub 2010 Sep 30. Clin Cancer Res. 2010. PMID: 20884624

5

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.

Tai WT, Cheng AL, Shiau CW, Huang HP, Huang JW, Chen PJ, Chen KF. Tai WT, et al. Among authors: shiau cw. J Hepatol. 2011 Nov;55(5):1041-8. doi: 10.1016/j.jhep.2011.01.047. Epub 2011 Feb 24. J Hepatol. 2011. PMID: 21354226

6

Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.

Chen KF, Tai WT, Huang JW, Hsu CY, Chen WL, Cheng AL, Chen PJ, Shiau CW. Chen KF, et al. Among authors: shiau cw. Eur J Med Chem. 2011 Jul;46(7):2845-51. doi: 10.1016/j.ejmech.2011.04.007. Epub 2011 Apr 14. Eur J Med Chem. 2011. PMID: 21531053

7

Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.

Tai WT, Cheng AL, Shiau CW, Liu CY, Ko CH, Lin MW, Chen PJ, Chen KF. Tai WT, et al. Among authors: shiau cw. Mol Cancer Ther. 2012 Feb;11(2):452-63. doi: 10.1158/1535-7163.MCT-11-0412. Epub 2011 Dec 16. Mol Cancer Ther. 2012. PMID: 22180308

8

A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.

Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW. Chen KF, et al. Among authors: shiau cw. Cancer Lett. 2012 Aug 1;321(1):27-35. doi: 10.1016/j.canlet.2012.03.023. Epub 2012 Mar 28. Cancer Lett. 2012. PMID: 22465052

9

CIP2A is a target of bortezomib in human triple negative breast cancer cells.

Tseng LM, Liu CY, Chang KC, Chu PY, Shiau CW, Chen KF. Tseng LM, et al. Among authors: shiau cw. Breast Cancer Res. 2012 Apr 26;14(2):R68. doi: 10.1186/bcr3175. Breast Cancer Res. 2012. PMID: 22537901 Free PMC article.

10

Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.

Chen KF, Lin JP, Shiau CW, Tai WT, Liu CY, Yu HC, Chen PJ, Cheng AL. Chen KF, et al. Among authors: shiau cw. Biochem Pharmacol. 2012 Aug 1;84(3):268-77. doi: 10.1016/j.bcp.2012.04.023. Epub 2012 May 9. Biochem Pharmacol. 2012. PMID: 22580047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters